LTRN
Lantern Pharma Inc

1,463
Mkt Cap
$41.83M
Volume
25,574.00
52W High
$6.12
52W Low
$2.55
PE Ratio
-2.05
LTRN Fundamentals
Price
$3.60
Prev Close
$3.74
Open
$3.74
50D MA
$3.81
Beta
1.39
Avg. Volume
73,540.53
EPS (Annual)
-$1.93
P/B
4.15
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Lantern Pharma Reports Third Quarter 2025 Financial Results and Provides Business Updates
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR artificial intelligence (AI) and machine learning (ML) platform to transform the cost...
Business Wire·30d ago
News Placeholder
More News
News Placeholder
Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company developing targeted and transformative cancer therapies using its proprietary RADR AI and machine learning (ML) platform...
Business Wire·1mo ago
News Placeholder
Lantern Pharma to Present AI-Driven Cancer Drug Development & Research Platforms at Inaugural AI for Biology and Medicine Symposium at UNT
Lantern Pharma Inc. (NASDAQ: LTRN) Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the...
Business Wire·1mo ago
News Placeholder
Lantern Pharma Presents LP-284 Clinical Data at 25th LL&M Congress, Highlighting Complete Response in Therapeutically Exhausted DLBCL Patient & Therapeutic Potential in Advanced B-Cell Cancers.
Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging its proprietary RADR artificial intelligence platform to transform oncology drug discovery and development...
Business Wire·2mo ago
News Placeholder
Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 30, 2025
Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology drug discovery and...
Business Wire·2mo ago

Latest LTRN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.